Zobrazeno 1 - 10
of 61
pro vyhledávání: '"HPV antibodies"'
Autor:
Pia Marie Albano, Christianne Salvador, Jose Orosa, Sheryl Racelis, Modesty Leaño, Angelika Michel, John Donnie Ramos, Dana Holzinger, Michael Pawlita
Publikováno v:
Journal of Pathology and Translational Medicine, Vol 53, Iss 5, Pp 273-279 (2019)
Background The low prevalence of human papillomavirus (HPV) DNA and mRNA in biopsy samples of Filipinos with head and neck squamous cell carcinoma (HNSCC) has been reported previously. Here, the HPV serologic profiles of HNSCC cases were analyzed and
Externí odkaz:
https://doaj.org/article/46794b36faef4b9b89598c1f059b6b28
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
The potential of first-void (FV) urine as a non-invasive method to monitor human papillomavirus (HPV) vaccination has been reported, mainly focusing on urine as a sample to assess HPV DNA. Besides HPV DNA, vaccine-induced HPV antibodies originating f
Externí odkaz:
https://doaj.org/article/45d7146f86b04f039ef314f95ca959f6
Autor:
Laura Téblick, Elizabeth R. Unger, Tim Waterboer, Alex Vorsters, Pierre Van Damme, Martina Willhauck-Fleckenstein, Gitika Panicker, Veerle Matheeussen, Severien Van Keer, Wiebren A.A. Tjalma, Jade Pattyn, Zoë Pieters
Publikováno v:
Article
Journal of medical virology
Journal of Medical Virology
Journal of medical virology
Journal of Medical Virology
Vaccine‐induced human papillomavirus (HPV) antibodies originating from cervicovaginal secretions were recently shown to be detectable in first‐void (FV) urine. This presents a novel opportunity for noninvasive sampling to monitor HPV antibody sta
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Frontiers in immunology
Frontiers in Immunology
Frontiers in immunology
Frontiers in Immunology
The potential of first-void (FV) urine as a non-invasive method to monitor human papillomavirus (HPV) vaccination has been reported, mainly focusing on urine as a sample to assess HPV DNA. Besides HPV DNA, vaccine-induced HPV antibodies originating f
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lucia Oton-Gonzalez, Elisa Mazzoni, Mauro Tognon, Andrea Ciorba, Maria Rosa Iaquinta, Chiara Bianchini, Ilaria Bononi, Carmen Lanzillotti, John Charles Rotondo, Luca Cerritelli, Nicola Malagutti, Fernanda Martini, Stefano Pelucchi
Publikováno v:
Cancers
Volume 13
Issue 13
Cancers, Vol 13, Iss 3370, p 3370 (2021)
Volume 13
Issue 13
Cancers, Vol 13, Iss 3370, p 3370 (2021)
Despite improved prognosis for many HPV-positive head and neck squamous cell carcinomas (HNSCCs), some cases are still marked by recurrence and metastasis. Our study aimed to identify novel biomarkers for patient stratification. Classical HPV markers
Autor:
Angelika Michel, Michael Pawlita, Jose Orosa, Sheryl Racelis, Pia Marie Albano, John Donnie A. Ramos, Christianne Salvador, Modesty Leaño, Dana Holzinger
Publikováno v:
Journal of Pathology and Translational Medicine
Journal of Pathology and Translational Medicine, Vol 53, Iss 5, Pp 273-279 (2019)
Journal of Pathology and Translational Medicine, Vol 53, Iss 5, Pp 273-279 (2019)
Background The low prevalence of human papillomavirus (HPV) DNA and mRNA in biopsy samples of Filipinos with head and neck squamous cell carcinoma (HNSCC) has been reported previously. Here, the HPV serologic profiles of HNSCC cases were analyzed and
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Elaine R. Tipton, Joseph J. Carter, David R. Doody, Margaret M. Madeleine, Lisa G. Johnson, Denise A. Galloway
Publikováno v:
Journal of Lower Genital Tract Disease
Recurrence of high-grade intraepithelial neoplasia of the vulva (VIN3) was less frequent among women with detectable human papillomavirus 16 antibodies.
Objectives Approximately 30% of women treated for squamous high-grade intraepithelial neopla
Objectives Approximately 30% of women treated for squamous high-grade intraepithelial neopla